Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Change in Acquisitions & Divestments (2010 - 2026)

Geron (GERN) posted Change in Acquisitions & Divestments of $86.6 million for Q1 2026, down 30.89% sequentially from $125.4 million in Q4 2025, and down 12.39% YoY from $98.9 million in Q1 2025.

Geron (GERN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Geron has reported Change in Acquisitions & Divestments for 17 years, with the latest figure at $86.6 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments fell 12.39% year-over-year to $86.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $399.5 million (up 7.95% YoY) and the FY2025 annual result came in at $411.7 million, up 10.79% from the prior year.
  • Change in Acquisitions & Divestments fell to $86.6 million in Q1 2026 per GERN's latest filing, from $125.4 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $179.8 million in Q4 2022 and troughed at $41.8 million in Q2 2022.
  • A 5-year average of $87.4 million and a median of $86.6 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments soared 2947.74% in 2022, then tumbled 64.68% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at $179.8 million in 2022, then sank by 64.68% to $63.5 million in 2023, then increased by 27.78% to $81.1 million in 2024, then jumped by 54.51% to $125.4 million in 2025, then plunged by 30.89% to $86.6 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $86.6 million, $125.4 million, and $90.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Geron 1.02 Mn -299.83 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 97.42 Mn
Jun 30, 2026 97.42 Mn
Mar 31, 2026 86.63 Mn
Mar 31, 2026 86.63 Mn
Dec 31, 2025 125.36 Mn
Dec 31, 2025 125.36 Mn
Sep 30, 2025 90.29 Mn
Sep 30, 2025 90.29 Mn
Jun 30, 2025 97.18 Mn
Jun 30, 2025 97.18 Mn
Mar 31, 2025 98.88 Mn
Mar 31, 2025 98.88 Mn
Dec 31, 2024 81.14 Mn
Dec 31, 2024 81.14 Mn
Sep 30, 2024 65.25 Mn
Sep 30, 2024 65.25 Mn
Jun 30, 2024 124.78 Mn
Jun 30, 2024 124.78 Mn
Mar 31, 2024 100.44 Mn
Mar 31, 2024 100.44 Mn